Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
March
01
COVID-19 vaccine development: Public funding yielded private profits
Medicare paid $704.2M for drug testing at risk of noncompliance with requirements
Immune-response test in study detects COVID-19 with near-perfect accuracy
Birmingham AIDS Outreach, Binx Health launch accessible HIV/STI testing program in Alabama
Myriad Genetics Q4 revenues rise 11% on strength in hereditary cancer, pharmacogenomics testing
Pathology services provider PathGroup adopts Proscia digital platform
University of Michigan breath analysis technology holds potential for COVID-19 detection
Page 1 of 1